Hoe verhoudt 1345's PE Ratio zich tot zijn concurrenten?

1345 is duur op basis van de Price-To-Earnings -ratio ( 13.6 x) vergeleken met het gemiddelde van de peer ( 12.1 x).

Hoe verhoudt 1345's PE Ratio zich tot andere bedrijven in de HK Healthcare industrie?

1345 is duur op basis van de Price-To-Earnings -ratio ( 13.6 x) vergeleken met het Hong Kong Healthcare -industriegemiddelde ( 13.1 x).

Wat is 1345's PE Ratio vergeleken met zijn Fair PE Ratio? Dit is de verwachte PE Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

Onvoldoende gegevens om de Price-To-Earnings Fair Ratio van { 1345 te berekenen voor waarderinganalyse.

Wat is de reële prijs van 1345 als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

1345 ( HK$2.05 ) handelt boven onze schatting van [[eerlijke waarde]] ( HK$0.4 )

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

Er zijn onvoldoende gegevens om een prijsvoorspelling te tonen.

Shanghai Pioneer Holding (SEHK:1345) - Aandelenkoers, Nieuws & Analyse

1345 Overzicht aandelen

Shanghai Pioneer Holding Ltd, een investeringsholding, verkoopt, promoot en promoot farmaceutische producten en medische hulpmiddelen voornamelijk in de Volksrepubliek China. Meer informatie

1345 fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	2/6
Financiële gezondheid	5/6
Dividenden	1/6

Risicoanalyse

Geen risico's gedetecteerd voor 1345 uit onze risicocontroles.

Shanghai Pioneer Holding Ltd Concurrenten

IVD Medical Holding

SEHK:1931

HK$2.7b

Tycoon Group Holdings

SEHK:3390

HK$2.9b

Charmacy Pharmaceutical

SEHK:2289

HK$1.0b

Sinco Pharmaceuticals Holdings

SEHK:6833

HK$365.9m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Shanghai Pioneer Holding
Historische aandelenkoersen
Huidige aandelenkoers	HK$2.05
52 Week Hoogtepunt	HK$2.26
52 Week Laag	HK$1.31
Bèta	0.45
11 maand verandering	7.89%
3 maanden verandering	-1.44%
1 Jaar Verandering	23.49%
33 jaar verandering	69.42%
5 jaar verandering	247.46%
Verandering sinds IPO	-46.61%

Recent nieuws en updates

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15

Recent updates

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29

Rendement voor aandeelhouders

	1345	HK Healthcare	HK Markt
7D	1.0%	-3.4%	0.05%
1Y	23.5%	-24.4%	11.5%

Rendement versus industrie: 1345 overtrof de Hong Kong Healthcare industrie, die het afgelopen jaar een rendement -24.4 % opleverde.

Rendement versus markt: 1345 overtrof de Hong Kong markt, die het afgelopen jaar een rendement opleverde van 11.5 %.

Prijsvolatiliteit

Is 1345's price volatile compared to industry and market?
1345 volatility
1345 Average Weekly Movement	6.3%
Healthcare Industry Average Movement	8.2%
Market Average Movement	9.0%
10% most volatile stocks in HK Market	18.9%
10% least volatile stocks in HK Market	4.2%

Stabiele aandelenkoers: 1345 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van 1345 is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1996	319	Steven Yang	www.pioneer-pharma.com

Shanghai Pioneer Holding Ltd, een investeringsmaatschappij, verkoopt, promoot en promoot farmaceutische producten en medische hulpmiddelen voornamelijk in de Volksrepubliek China. Het bedrijf biedt farmaceutische producten voor oogheelkunde, pijnbestrijding, hart- en vaatziekten, immunologie, gynaecologie, gastro-enterologie en andere therapeutische gebieden. Het verkoopt ook medische hulpmiddelen, waaronder producten voor oogheelkunde, orthopedie, odontologie en wondverzorging.

Shanghai Pioneer Holding Ltd Samenvatting

Hoe verhouden de winst en inkomsten van Shanghai Pioneer Holding zich tot de beurswaarde?
1345 fundamentele statistieken
Marktkapitalisatie	HK$2.35b
Inkomsten(TTM)	HK$175.92m
Inkomsten(TTM)	HK$1.77b

13.6x

Koers/Winstverhouding

1.3x

P/S-verhouding

Is 1345 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1345 resultatenrekening (TTM)
Inkomsten	CN¥1.65b
Kosten van inkomsten	CN¥945.43m
Brutowinst	CN¥702.31m
Overige uitgaven	CN¥538.63m
Inkomsten	CN¥163.67m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.14
Brutomarge	42.62%
Nettowinstmarge	9.93%
Schuld/Eigen Vermogen Verhouding	6.1%

Hoe presteerde 1345 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.3%

Huidig dividendrendement

47%

Uitbetalingsratio

1345 Overzicht aandelen

Risicoanalyse

Shanghai Pioneer Holding Ltd Concurrenten

SEHK:1931

HK$2.7b

SEHK:3390

HK$2.9b

SEHK:2289

HK$1.0b

SEHK:6833

HK$365.9m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Upcoming dividend of HK$0.048 per share

First half 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.065 in 1H 2023)

Shanghai Pioneer Holding Ltd Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2024, Payable on 15 November 2024

Shanghai Pioneer Holding Ltd to Report First Half, 2024 Results on Aug 28, 2024

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Upcoming dividend of HK$0.024 per share

Recent updates

Upcoming dividend of HK$0.048 per share

First half 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.065 in 1H 2023)

Shanghai Pioneer Holding Ltd Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2024, Payable on 15 November 2024

Shanghai Pioneer Holding Ltd to Report First Half, 2024 Results on Aug 28, 2024

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Upcoming dividend of HK$0.024 per share

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Investor sentiment improves as stock rises 21%

Final dividend of HK$0.024 announced

Shanghai Pioneer Holding Ltd, Annual General Meeting, May 24, 2024

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2023 Results on Mar 25, 2024

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Now 23% overvalued

New minor risk - Share price stability

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Less than half of directors are independent

Shanghai Pioneer Holding Ltd Announces Board Changes

New major risk - Earnings quality

Upcoming dividend of HK$0.024 per share at 3.0% yield

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

First half 2023 earnings released: EPS: CN¥0.065 (vs CN¥0.10 in 1H 2022)

Shanghai Pioneer Holding Ltd Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on October 20, 2023

Shanghai Pioneer Holding Ltd to Report First Half, 2023 Results on Aug 29, 2023

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Investor sentiment deteriorates as stock falls 15%

Upcoming dividend of HK$0.048 per share at 2.4% yield

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Investor sentiment improves as stock rises 23%

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings released

Shanghai Pioneer Holding Ltd Provides Earnings Guidance for the Year Ended 31 December 2022

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2022 Results on Mar 27, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Less than half of directors are independent

Upcoming dividend of HK$0.018 per share

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings Limited Announces Management Changes

Investor sentiment improved over the past week

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.057 in 1H 2021)

China Pioneer Pharma Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 20 October 2022

China Pioneer Pharma Holdings Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of HK$0.064 per share

Less than half of directors are independent

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings Limited, Annual General Meeting, May 18, 2022

Full year 2021 earnings released: EPS: CN¥0.12 (vs CN¥0.043 in FY 2020)

China Pioneer Pharma Holdings Limited Announces Dividend for the Year Ended 31 December 2021, Payable on 10 June 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings Limited to Report Fiscal Year 2021 Results on Mar 31, 2022